FDA Inspection 1271390 — Lancaster General Women and Babies Hospital Blood Bank
The FDA completed an inspection of Lancaster General Women and Babies Hospital Blood Bank on May 21, 2025 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)